MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great…
SOUTH SAN FRANCISCO, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the Medicines and Healthcare products Regulatory…